問題 › 新規市場への参入を検討すべきか › 物流・サプライチェーン
市場規模と成長率は把握しやすい半面、既存の収益 per loaded mile、積載率、ドライバー定着率が移行可能かどうかが結果を決めます。 物流・運送会社に当てはまる問いは一般論とは異なります。専用輸送は利益率を低下させやすい一方で、ドライバー離職を改善する唯一の手段でもあります。よって loaded mile あたりの収益を無視した答えは誤りになりやすく、分析はドライバー離職率と deadhead 比率から始める必要があります。
市場規模と成長率は把握しやすい半面、既存の収益 per loaded mile、積載率、ドライバー定着率が移行可能かどうかが結果を決めます。 物流・運送会社に当てはまる問いは一般論とは異なります。専用輸送は利益率を低下させやすい一方で、ドライバー離職を改善する唯一の手段でもあります。よって loaded mile あたりの収益を無視した答えは誤りになりやすく、分析はドライバー離職率と deadhead 比率から始める必要があります。
新路線や専用契約は輸送量と成長率で評価されがちですが、いずれも予測可能でも成功を保証しません。予測に有効なのは、既存のドライバープール、deadhead を削減する backhaul、荷主との関係など、すでに保有していて新市場で活かせる要素と、新たに構築しなければならない要素です。
輸送量の見込みが強くても、ドライバー離職率や operating ratio が既存事業より悪化する場合は不適切です。逆に成長率が低くても、deadhead が低く積載率が高い状態で始められる路線の方が、すべての指標が同等で始める拡大路線より成果を上げやすいものです。
もう一つの原則は参入前に撤退基準を明文化しておくことです。専用輸送や新路線は、輸送量が増えれば operating ratio が改善すると主張され、ドライバーと整備予算を長年静かに消費しやすい特性があります。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ 参入根拠が路線輸送量と成長率の予測のみで、現在の事業との loaded mile あたりの収益やドライバー離職率の比較がない。
✓ operating ratio、deadhead 比率、ドライバー離職率について、撤退を判断する数値基準が書面化されていない。
✓ 既存の収益 per mile と積載率が横ばいで、新路線や契約で全体を押し上げようとしている。
通常、事態を悪化させる対応です。 既存の専用輸送とスポット輸送の組み合わせが行き詰まっているため参入を検討し、管理リソースとドライバーをすでに運行中の路線の改善から引き離してしまう。
It is for you if you run or finance a freight company and the case rests mainly on market size and growth rate. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 運送会社. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Ridgeway Freight Systems, a sample company profile used for testing rather than a customer — $240M revenue, 900 drivers.
Excerpt from a real Percision run · Cost Reduction & Efficiency · sample company profile
The move. Leverage paid-for terminal density to raise pricing on 50 lanes and reinvest the gains into driver retention, creating a self-funding margin-expansion flywheel.
| Investment required | $0.6–0.9M over 36 months (pricing engine + retention bonuses) |
| Expected return | Base case: $4.2–6.3M incremental annual revenue at 85%+ incremental margin, yielding 7–10× ROI on the $0.9M investment within 24 months. |
| Revenue, year 1 | $289–293M |
| Revenue, year 2 | $298–306M |
| Revenue, year 3 | $310–320M |
| Exit criteria | Strategy should be reversed if, within 12 months, net revenue per hundredweight on the 50 lanes has not increased by at least 2% OR if driver turnover has not declined below 75% by Month 18, OR if one of the two $25M dedicated contracts is lost at renewal without a 1%+ rate increase. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 市場参入・拡大戦略, one of 29 engagements the platform runs. For 物流・運送会社 it works through revenue per loaded mile, driver turnover, deadhead percentage and operating ratio, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
新市場が評価する自社の保有資産と、そこで確立した競合が保有し自社にない資産をそれぞれ列挙します。後者が長く、構造的な要素（流通網、規制、データ蓄積など）を含む場合は、参入は新規構築となり、既存事業の延長ではありません。
開始前に数値を定め、それを上回った場合は追加投資ではなく撤退基準として扱います。失敗した参入の多くは撤退されず、徐々に資金を失うだけでした。
すでに保有する資産をより多く再利用できる方を選びます。地理的拡大は製品を再利用し流通を再構築しやすく、新規セグメントは流通を再利用し製品を再構築しやすくなります。再構築の規模が小さい方が安全です。
Materially, yes. Dedicated freight dilutes margin and is also the only thing that fixes driver turnover — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are revenue per loaded mile, driver turnover, deadhead percentage, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on revenue per loaded mile and driver turnover. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית